Speaker
Founder, President & Chief Executive Officer, Origami Therapeutics, Inc.
Beth Hoffman, Founder, President & Chief Executive Officer at Origami Therapeutics, Inc., is speaking at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Phenotypic Screening to Identify & Optimize Protein Degraders for CNS Disorders Acting Through the Autophagy-Lysosome Pathway”.
26–29 Oct 2026Boston, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Beth Hoffman, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].